Trinity Innovation Fund

Trinity Innovation Fund is a venture capital firm specializing in biomedical innovations, focusing on early-stage investments in the biomedical sector. Established in 2018, the firm manages multiple funds with different focuses, including a fund dedicated to biomedical innovations. Their limited partners include renowned biopharmaceutical companies and investment institutions. The firm's investment team comprises experienced professionals with backgrounds in biopharmaceuticals, finance, and academia, who have managed multiple VC funds and invested in numerous biotech companies. Trinity Innovation Fund has been recognized for its contributions to the biomedical investment sector, receiving awards such as the Best Biomedical Investment Institution in 2023 and the Top 15 Biomedical Investment Institution in 2021. The firm is headquartered in Beijing, China, with an office in Singapore, and continues to focus on nurturing innovative biomedical companies in Asia and globally.

Trinity Innovation Fund is a venture capital firm specializing in biomedical innovations, focusing on early-stage investments in the biomedical sector. Established in 2018, the firm manages multiple funds with different focuses, including a fund dedicated to biomedical innovations. Their limited partners include renowned biopharmaceutical companies and investment institutions. The firm's investment team comprises experienced professionals with backgrounds in biopharmaceuticals, finance, and academia, who have managed multiple VC funds and invested in numerous biotech companies. Trinity Innovation Fund has been recognized for its contributions to the biomedical investment sector, receiving awards such as the Best Biomedical Investment Institution in 2023 and the Top 15 Biomedical Investment Institution in 2021. The firm is headquartered in Beijing, China, with an office in Singapore, and continues to focus on nurturing innovative biomedical companies in Asia and globally.

Trinity Innovation Fund is a venture capital firm specializing in biomedical innovations, focusing on early-stage investments in the biomedical sector. Established in 2018, the firm manages multiple funds with different focuses, including a fund dedicated to biomedical innovations. Their limited partners include renowned biopharmaceutical companies and investment institutions. The firm's investment team comprises experienced professionals with backgrounds in biopharmaceuticals, finance, and academia, who have managed multiple VC funds and invested in numerous biotech companies. Trinity Innovation Fund has been recognized for its contributions to the biomedical investment sector, receiving awards such as the Best Biomedical Investment Institution in 2023 and the Top 15 Biomedical Investment Institution in 2021. The firm is headquartered in Beijing, China, with an office in Singapore, and continues to focus on nurturing innovative biomedical companies in Asia and globally.